Journal of
AIDS and HIV Research

  • Abbreviation: J. AIDS HIV Res.
  • Language: English
  • ISSN: 2141-2359
  • DOI: 10.5897/JAHR
  • Start Year: 2009
  • Published Articles: 299

Full Length Research Paper

Time for initiation of antiretroviral therapy in HIV co-infected tuberculosis patients in Addis Ababa, Ethiopia

Kassa Haile
  • Kassa Haile
  • Training Department, ALERT Centre, Addis Ababa, Ethiopia.
  • Search for this author on:
  • Google Scholar
Girum Zewdu
  • Girum Zewdu
  • Federal Ministry of Health, Department of Maternal and Child Health, Addis Ababa,, Ethiopia.
  • Search for this author on:
  • Google Scholar
Eveline Klinkenberg
  • Eveline Klinkenberg
  • KNCV Tuberculosis Foundation, Ethiopia.
  • Search for this author on:
  • Google Scholar
Desalegn Woldeyohannes
  • Desalegn Woldeyohannes
  • Aklilu Lemma Institute of Pathobiology, Addis Ababa University, Addis Ababa, Ethiopia.
  • Search for this author on:
  • Google Scholar


  •  Received: 10 October 2017
  •  Accepted: 04 December 2017
  •  Published: 31 March 2018

References

Abdool Karim SS, Naidoo K, Grobler A, Padayatchi N, Baxter C, Gray A, Gengiah T, Nair G, Bamber S, Singh A, Khan M (2010). Timing of Initiation of Antiretroviral Drugs during Tuberculosis Therapy. N. Engl. J. Med. 362(8):697-706.
Crossref
 

Alemayehu YK, Bushen OY, Muluneh AT (2009). Evaluation of HIV/AIDS clinical care quality: the case of a referral hospital in North West Ethiopia. Int. J. Q. Health Care 21(5):356-362.
Crossref

  
 

Chilton D, Edwards SG, Pellegrino P, Miller RF (2008). Factors influencing delay in initiating antiretroviral therapy among HIV infected patients coinfected with tuberculosis. Thorax 63(10):935-936.
Crossref

  
 

Denegetu AW, Dolamo BL (2014). HIV screening among TB patients and co-trimoxazole preventive therapy for TB/HIV patients in Addis Ababa: facility based descriptive study. PloS one 9(2):e86614. Dis. 15(1):536.
Crossref

  
 

FDRE Population Census Commission (2007). Summary and Statistical Report of the 2007 Population and Housing Census, Population Size by Age and Sex. Available at: 

View

  
 

Federal Ministry of Health (FMOH) (2007). Implementation Guideline for TB/HIV Collaborative Activities in Ethiopia. Available at: 

View

  
 

Federal Ministry of Health (FMOH) (2013). Guidelines for Clinical and Programmatic Management of Tb, Tb/hiv and Leprosy in Ethiopia Fifth Edition. Available at: 

View

  
 

Franke MF, Robins JM, Mugabo J, Kaigamba F, Cain LE, Fleming JG, Murray MB (2011). Effectiveness of Early Antiretroviral Therapy Initiation to Improve Survival among HIV-Infected Adults with Tuberculosis: A Retrospective Cohort Study. PLoS Med. 8(5):e1001029.
Crossref

  
 

Kapata N, Chanda‐Kapata P, Grobusch MP, O'Grady J, Schwank S, Bates M, Jansenn S, Mwinga A, Cobelens F, Mwaba P, Zumla A (2012). Scale-up of TB and HIV Programme Collaborative Activities in Zambia - a 10-Year Review. Trop. Med. Int. Health 17:760-766.
Crossref

  
 

Lawn SD, Campbell L, Kaplan R, Little F, Morrow C, Wood R, Africa IS (2011). Delays in Starting Antiretroviral Therapy in Patients with HIV-Associated Tuberculosis Accessing Non-Integrated Clinical Services in a South African Township. BMC Infect. Dis. 11(1):258.
Crossref

  
 

Lawn SD, Kranzer K, Wood R (2009). Antiretroviral therapy for control of the HIV-associated tuberculosis epidemic in resource-limited settings. Clin. Chest Med. 30(4):685-699.
Crossref

  
 

Naidoo K, Baxter C, Karim SSA (2013). When to start antiretroviral therapy during tuberculosis treatment. Curr. Opin. Infect. Dis. 26(1):35-42.
Crossref

  
 

Nglazi MD, Bekker LG, Wood R, Kaplan R (2015). The impact of HIV status and antiretroviral treatment on TB treatment outcomes of new tuberculosis patients attending co-located TB and ART services in South Africa: a retrospective cohort study. BMC Infect.
Crossref

  
 

Salim S. Abdool K, Naidoo K, Grobler A, Padayatchi N, Baxter C, Gray AL, Gengiah T, Gengiah S, Naidoo A, Jithoo N, Nair G, El-Sadr WM, Friedland G, Karim QA (2011). Optimal Timing of Antiretroviral Therapy during Tuberculosis Treatment : The SAPiT trial, 17th Conference of Retroviruses and Opportunistic Infections Boston, 28 February 2011. Available at: 

View

  
 

Sileshi B, Deyessa N, Girma B, Melese M, Suarez P (2013). Predictors of mortality among TB-HIV Co-infected patients being treated for tuberculosis in Northwest Ethiopia: a retrospective cohort study. BMC Infect. Dis. 13(1):297.
Crossref

  
 

Stockdale AJ, Nkuranga J, Török ME, Faragher B, Lalloo DG (2013). Initiation of antiretroviral therapy in HIV‐infected tuberculosis patients in rural Kenya: An observational study. Trop. Med. Int. Health 18(7):907-914.
Crossref

  
 

Tayler‐Smith K, Zachariah R, Manzi M, Kizito W, Vandenbulcke A, Sitienei J, Chakaya J, Harries AD (2011). Antiretroviral Treatment Uptake and Attrition among HIV-Positive Patients with Tuberculosis in Kibera, Kenya. Trop. Med. Int. Health 16(11):1380-1383.
Crossref

  
 

World Health Organization (2015). Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. In Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV.

  
 

World Health Organization (WHO) (2010). Antiretroviral Therapy for HIV Infection in Adults and Adolescents Recommendations for a Public Health Approach. Available at: 

View

  
 

World Health Organization (WHO) (2014). Zhurnal Eksperimental'noi i Teoreticheskoi Fiziki Global TB Report. Available at: 

View

  
 

World Health Organization PEPFAR, UNAIDS (2015). Guide to Monitoring and Evaluation for Collaborative TB/HIV Activities--2015 Update. World Health Organization.

  

 

Copyright © 2024 Author(s) retain the copyright of this article.

This article is published under the terms of the Creative Commons Attribution License 4.0

Back to Vol. 10 No. 3
Back to articles
SUBSCRIBE TO RSS
SUBMIT MANUSCRIPT
CONFERENCES